Multisystemic Complications and Rapid Decline in Anti‐MDA‐5 Positive Amyopathic Dermatomyositis: A Case Study
Hem Prajapati, Yesha R. Chauhan, Sahaj Y. Patel, Ajay C. Parmar, Tasin Mohammedyakub Shaikhjiwala
TL;DR
This case study shows how a rare autoimmune disease can quickly cause severe health issues, emphasizing the importance of early diagnosis and treatment.
Contribution
The case highlights the aggressive progression of anti-MDA-5 positive amyopathic dermatomyositis and the importance of timely immunosuppressive therapy.
Findings
Anti-MDA-5 positive amyopathic dermatomyositis can rapidly lead to severe interstitial lung disease.
Early diagnosis and comprehensive immunosuppressive therapy are crucial for improving outcomes in this condition.
Abstract
Anti‐MDA‐5 positive amyopathic dermatomyositis (CADM) can lead to rapid multisystemic complications, including severe interstitial lung disease (ILD). This case, involving a 60‐year‐old female with worsening skin lesions and ILD, demonstrates the disease's aggressive nature, highlighting the need for early diagnosis and comprehensive immunosuppressive therapy to improve patient outcomes.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Myopathies and Dermatomyositis · Dermatological and Skeletal Disorders · Heterotopic Ossification and Related Conditions